Clinical trials
Helicobacter Infection clinical trials
Below are recruiting helicobacter infection clinical trials, each written for real people, not researchers. We’re tracking 65 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05247112Recruiting
Tracking antibiotic resistance in H. pylori infections in Korea
This study looks at how resistant H. pylori (a stomach germ) is to different antibiotics in Korea. It uses stomach endoscopy samples to test which antibiotics may or may not work, helping guide future treatment choices.
Seongnam-si, Gyeonggi-doAges Any age - NCT07045688Recruiting
Vonoprazan for Helicobacter pylori infection
This trial tests vonoprazan-based treatments to see if they can effectively clear H. pylori infection. It may help if you have not been treated for H. pylori before.
SohagAges 19 years+ - NCT06529159Recruiting
Treating H. pylori with argon plasma during endoscopy
This trial tests a new way to treat H. pylori infection using argon plasma (a kind of energy) during an upper endoscopy. It may help people who haven't yet taken antibiotics for H. pylori and are already having an endoscopy.
Boston, MassachusettsAges 18 years+ - NCT07293910RecruitingPhase 2
Comparing treatments for H. pylori infection
This trial tests whether a new type of acid-reducing drug (vonoprazan) works better than a common one (proton pump inhibitor) when combined with vitamin D or probiotics to clear H. pylori, a bacteria that can cause stomach problems. If you have H. pylori and haven't been treated for it before, this study may be for you.
TantaAges 18–80 - NCT07335406Recruiting
H. pylori infection registry study in Shandong
This study is creating a registry of people with Helicobacter pylori (H. pylori) infection in Shandong Province who choose to have treatment. It will gather information to improve how H. pylori infections are managed.
Jinan, ShandongAges 18–80 - NCT06546111RecruitingPhase 1/Phase 2
Diosmin and hesperidin for H. pylori infection
This trial tests whether a combination of two natural plant compounds, diosmin and hesperidin, can safely and effectively treat Helicobacter pylori (H. pylori) infection in people who have not been treated for it before. The goal is to see if this therapy offers a new option for clearing the bacteria.
Shibīn al KawmAges 18–75 - NCT05332444RecruitingPhase 4
Check if stomach-bacteria testing improves rescue treatment for H. pylori
This study compares two ways to treat Helicobacter pylori (H. pylori) infection that didn’t go away with prior therapy. One approach uses test results to guide which medicines to use, and the other uses standard (“empiric”) treatment. The goal is to see which works better and more safely as a rescue plan.
TaipeiAges 20 years+ - NCT07142798Enrolling by invitation
14-day triple therapy for H. pylori infection
This trial tests a 14-day treatment using bismuth, amoxicillin, and a stomach acid reducer (PCAB) to see how well it clears H. pylori, a bacteria that can cause stomach ulcers. It may be an option if you have H. pylori and haven't had stomach surgery or certain serious health conditions.
Kaohsiung CityAges 18–80 - NCT05121025Recruiting
Study of stomach bacteria and gut microbes in Helicobacter infection
This study looks at how stomach bacteria (Helicobacter pylori) interact with the normal microbes in your gut. You may be asked to provide tissue, stool, and blood samples to help researchers understand infection and the body’s response.
Freiburg im Breisgau, Baden-WurttembergAges 18 years+ - NCT06561698RecruitingPhase 4
High-dose dual therapy vs minocycline quadruple therapy for H. pylori
This trial compares two treatments for H. pylori infection: a high-dose two-drug regimen and a four-drug regimen containing minocycline. It aims to find which is more effective and better tolerated.
Hebi, HenanAges 18–70 - NCT07704255RecruitingPhase 4
Fecal transplant for stubborn H. pylori infection
This study tries a fecal microbiota transplant (placing healthy donor stool into your gut) to get rid of stubborn H. pylori infection that hasn't been cured by standard treatments. It's for people who have failed several rounds of therapy and have a stomach condition that makes eradication important.
Chengdu, SichuanAges 18–80 - NCT05561504Recruiting
Study of stomach bacteria resistance in adults
This study looks at how common a stomach bacteria infection is and which antibiotics still work. You may help researchers by providing consent for related study participation and sample tracking.
MunichAges 18 years+ - NCT05762991Recruiting
AI test to help diagnose stomach bacteria and early stomach changes
This trial checks whether an artificial intelligence (computer) system can help diagnose Helicobacter pylori (a common stomach bacteria) and early stomach “premalignant” changes using endoscopy results. It may help doctors spot problems more accurately when you have a scheduled scope.
TaipeiAges 20–80 - NCT07285096Recruiting
New quadruple therapy for H. pylori infection
This trial tests a combination of four medications to treat H. pylori, a bacteria that can cause stomach ulcers and other issues. The goal is to see if this newer therapy works well for people who are infected.
JinanAges 18–70 - NCT02373280Recruiting
7-day tailored treatment to clear H. pylori infection
This trial tests whether a personalized 7-day treatment plan can fully get rid of H. pylori, a common stomach germ. It may help prevent ongoing stomach irritation and ulcers caused by the infection.
Seongnam-si, Gyeonggi-doAges 18–85 - NCT07537634RecruitingPhase 4
New stomach acid medicine versus standard treatment for H. pylori infection
This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.
DhakaAges 18 years+ - NCT04332848RecruitingPhase 4
Testing-guided treatment for stubborn stomach H. pylori
This trial studies whether using lab testing to guide antibiotic choice works better than using a standard (empirical) treatment plan for stubborn H. pylori infection. You might benefit if past treatments have not cleared the infection after multiple attempts.
TaipeiAges 20–90 - NCT06734260RecruitingPhase 3
Optimizing a two-drug therapy for H. pylori infection
This trial tests a two-drug combination (keverprazan and amoxicillin) to see if it works better for treating H. pylori, a bacteria that can cause stomach problems. It is for people who have had H. pylori before and need treatment again.
Guangzhou, GuangdongAges 18–75 - NCT07165444Recruiting
Comparing two acid-blocking drugs for H. pylori treatment
This trial tests if a newer acid-blocking medicine works better than a standard one when given with antibiotics and bismuth for treating H. pylori infection, a bacteria that can cause stomach ulcers. It is for adults who have not had treatment for H. pylori before.
Tanta, El-GharbiaAges 18 years+ - NCT06422052Recruiting
H. pylori infection and its treatment for stomach discomfort
This trial is for adults aged 18 to 80 who have a Helicobacter pylori (H. pylori) infection in their stomach and have never been treated for it. The study will look at how treating the infection affects symptoms like indigestion or stomach pain.
Chongqing, Chongqing MunicipalityAges 18–80 - NCT04713670RecruitingPhase 4
Tested medicines to cure new H. pylori infection
This trial compares different stomach-medicine combinations to eliminate a new (first-time) H. pylori infection. It may help find the most effective treatment approach for people who have never tried eradication therapy before.
TaipeiAges 20 years+ - NCT02328131Recruiting
Registry study for adults with H. pylori infection
This study is a registry that follows adults who have Helicobacter pylori (a common stomach bacteria) to learn how it’s managed in real life. It may help improve care by tracking treatments and outcomes over time.
ViennaAges 18 years+ - NCT06723197RecruitingPhase 4
Comparing treatment lengths for H. pylori infection
This trial compares different lengths of treatment with two or four medications to see which works best for clearing H. pylori, a stomach bacteria that can cause ulcers. It is for people who have not been treated for this infection before.
Jinan, ShandongAges 18–70 - NCT07576959RecruitingPhase 3
Bismuth with dual therapy for H. pylori infection treatment
This trial tests whether adding bismuth (a mineral compound) to standard two-drug therapy helps cure H. pylori, a common stomach bacteria that can cause ulcers and inflammation. The goal is to see if this combination works better than dual therapy alone.
TaipeiAges 20 years+
Hear when a new Helicobacter Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for helicobacter infection?
- Yes. Clin2 currently lists 65 recruiting helicobacter infection studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a helicobacter infection trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a helicobacter infection trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.